The purpose of this paper was to investigate the accuracy of three dimensional (3D) ultrasound (US)-guided large core needle biopsies (LCNB) in the diagnosis of breast cancers.
Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification.
Sauer G, Deissler H, Strunz K, Helms G, Remmel E, Koretz K, Terinde R, Kreienberg R
Purpose
Conclusion
The sensitivity and specificity of 3D-US-guided LCNB for detection of infiltrating carcinoma were 96.1% and 100%, respectively. There was complete agreement between LCNB and surgical specimens in the diagnosis for 96.2% lesions and complete disagreement in 1.8% (11 lesions). Although 8 of these were originally assigned a breast imaging reporting and data system (BI-RADS) score of IV (suspicious abnormality) or V (suspicious of malignancy), the remaining 3 were originally diagnosed as benign. Lesion size, number of biopsies, and palpability were not found to be significantly different between malignancies missed by LCNB and those found by LCNB. In 75.9% of cases, two specimens were sufficient for diagnosis.
Studies (1)
Purpose
The purpose of this study was to investigate the accuracy of 3D-US guided LCNB in the diagnosis of breast cancers and to determine the effect of lesion palpability, lesion size, and number of specimens. LCNB were obtained from 962 lesions from 906 patients by 1 of 3 technicians using a biopsy gun fitted with a 14-gauge needle. Once the needle was placed at the edge of the lesion under 2D-US guidance, the needle was fired with a 22 mm throw and biopsy location was confirmed to be within the lesion under 3D-US. Final diagnosis was based on follow-up imaging as well as histology of the LCNB and surgical specimen, when available.
Summary of Findings
The sensitivity and specificity of 3D-US guided LCNB for detection of infiltrating carcinoma were 96.1% and 100%, respectively and 97.9% of malignant lesions were identified by LCNB. For the 659 lesions with surgical excisional specimens, there was complete agreement in the diagnosis for 96.2% (635) lesions, partial agreement (i.e., DCIS found to contain invasive component, atypical ductal hyperplasias upgraded to DCIS or atypical ductal hyperplasias upgraded to infiltrating carcinoma) in 2% (13) lesions and complete disagreement in 1.8% (11 lesions). Importantly, all 11 missed diagnoses were sonographic masses in which the biopsy hit the center of the lesion. Although 8 of these were originally assigned a breast imaging reporting and data system (BI-RADS) score of IV (suspicious abnormality) or V (suspicious of malignancy), the remaining 3 were originally diagnosed as benign. Lesion size, number of biopsies, and palpability were not found to be significantly different between malignancies missed by LCNB and those found by LCNB. In 75.9% of cases, two specimens were sufficient for diagnosis.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaNeoplasticBenignPlatforms
MorphologyLight microscopyMorphologyX-rayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen heterogeneity Intratumoral sampling (exact positions not specified)